UBS Lowers Numbers on CME Group (CME) Post Q3, Maintains Buy on Upside Opportunity
Tweet Send to a Friend
UBS trimmed estimates and its price target on CME Group (NASDAQ: CME) from $66 to $64 but kept its Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
